Revenio Group Plc.'s long term CEO Olli-Pekka Salovaara (born 1960) will leave his position after a transition period on January 1, 2017 and he will continue in the position of Executive Chairman of the Board of Icare USA Inc.'s. The company's board of directors has appointed M.Sc. Timo Hildén (born 1959) as the new Group CEO as of January 1, 2017. Hildén has worked as the CEO of Revenio Group's subsidiary Icare Finland since April 2012.

The Management Team of Revenio Group will be expanded as of June 1, 2016 and the members will be Revenio Group Plc's CEO Olli-Pekka Salovaara (until December 31, 2016), Icare Finland Ltd.'s CEO and Segment Director of Revenio Health Tech Timo Hilden, Revenio Group Plc's CFO Robin Pulkkinen, Sales and Marketing Director Tomi Karvo, Revenio Research Oy's R&D Director Ari Kukkonen and Icare Finland Ltd.'s Operations Director Ari Isomäki as a new member. Also, Tiina Olkkonen is attending Management Team meetings as an external communication specialist and Management Team secretary. In addition, an Extended Management Team that meets on quarterly basis is established as of June 1, 2016, consisting of Management Team members and the CEO of Icare USA Inc. John Floyd.